Archive: 31/10/2013

Results of the CHILL-MI trial presented

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Novo Nordisk earnings narrowly miss expectations

Novo Nordisk, the world's biggest producer of insulin for diabetes sufferers, posted a quarterly profit that narrowly missed expectations, and issued a cautious outlook for next year on Thursday.

page 7 from 9